# Avista Pharma Solutions, Inc. dba Cambrex, Durham, NC – FDA Inspections

Source: https://www.keypedia.com/companies/avista-pharma-solutions-inc-dba-cambrex/56214bca-3cc9-496a-a019-aab43c351824

> Inspection records and compliance data for Avista Pharma Solutions, Inc. dba Cambrex in Durham, North Carolina. 4 FDA inspections on record, last inspected July 03, 2025.

---

## Details

- Name: Avista Pharma Solutions, Inc. dba Cambrex
- FEI Number: 3011795391
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING
- Address Line 1: 3501 Tricenter Blvd Ste C
- City: Durham
- State: North Carolina
- Zip Code: 27713
- Country Name: United States
- Address: 3501 Tricenter Blvd Ste C, Durham, North Carolina 27713, United States
- Country: United States

## Related Documents

- [FDA Inspection 1277419 - Avista Pharma Solutions, Inc. dba Cambrex - 2025-07-03](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/8a4208ef-dcad-47c0-9bbd-2ab3cdc26b19) — source: FDA, date: July 3, 2025
- FDA Inspection 1277419 - Avista Pharma Solutions, Inc. dba Cambrex - 2025-07-03 — classification: No Action Indicated (NAI), source: FDA, date: July 3, 2025
- [FDA Inspection 1128465 - Avista Pharma Solutions, Inc. dba Cambrex - 2020-07-17](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/ee45f26b-b044-435f-9d45-4363448c47de) — classification: No Action Indicated (NAI), source: FDA, date: July 17, 2020
- FDA Inspection 805222 - Avista Pharma Solutions, Inc. dba Cambrex - 2012-10-30 — classification: No Action Indicated (NAI), source: FDA, date: October 30, 2012
- FDA Inspection 636454 - Avista Pharma Solutions, Inc. dba Cambrex - 2009-10-09 — classification: No Action Indicated (NAI), source: FDA, date: October 9, 2009

## Related Companies

- [Liquidia Technologies, Inc.](https://www.keypedia.com/companies/liquidia-technologies-inc/4c70764b-1078-4221-a9a3-804b2e1be087)
- [3M Company](https://www.keypedia.com/companies/3m-company/2cb29977-0876-46cd-88ee-7c37ec8ca321)
- [Shire Human Genetic Therapies, Inc.](https://www.keypedia.com/companies/shire-human-genetic-therapies-inc/1d1f96ea-a020-4019-96a3-aee02e95246e)
- [Nivagen Pharmaceuticals Inc](https://www.keypedia.com/companies/nivagen-pharmaceuticals-inc/3eba9a8d-d560-49ef-956e-aa59eea20360)
- [Incog Biopharma Services, Inc.](https://www.keypedia.com/companies/incog-biopharma-services-inc/6e8ec293-9414-4eec-921f-5e0ca40b7b20)
- [Biospectra, Inc.](https://www.keypedia.com/companies/biospectra-inc/bb32a74e-c76f-4ea1-b504-bf2a62f1795d)
- [Beijing Sciecure Pharmaceutical Co Ltd](https://www.keypedia.com/companies/beijing-sciecure-pharmaceutical-co-ltd/3c81eb24-325a-4469-b2e3-4c62b80fdf86)
- [Novo Nordisk Production Ireland Limited](https://www.keypedia.com/companies/novo-nordisk-production-ireland-limited/86c23511-86fb-483e-8ae2-8d243d7f3ee6)
- [MSD International GmbH (Singapore Branch)](https://www.keypedia.com/companies/msd-international-gmbh-singapore-branch/3d456461-5850-422d-9d7e-58d14803d018)
- [Astellas Ireland Co Ltd](https://www.keypedia.com/companies/astellas-ireland-co-ltd/864f5eab-cb32-4cfe-96b5-f52e4224a64d)